Hemophilia Markets Poised for Evolution as Competitive Dynamics between Hemlibra (Roche/Genentech) and Altuviiio (Sanofi) Intensify and Hympavzi (Pfizer) Receives Approval, According to Spherix Global Insights
14 oct. 2024 12h33 HE
|
Spherix Global Insights
EXTON, PA, Oct. 14, 2024 (GLOBE NEWSWIRE) -- Hemophilia, a genetic disorder that impairs blood clotting, affects thousands of people worldwide. The treatment landscape is rapidly evolving, fueled by...
Hematology Collaboration and Licensing Deals Analysis Report and Directory 2024: Company A-Z, Headline Value, Therapeutic Area, Technology Type, Royalties
30 sept. 2024 05h14 HE
|
Research and Markets
Dublin, Sept. 30, 2024 (GLOBE NEWSWIRE) -- The "Hematology Collaboration and Licensing Deals 2016-2024" report has been added to ResearchAndMarkets.com's offering.The report provides access to deal...
2024 Annual Eric Dostie Memorial College Scholarship Recipients
24 sept. 2024 13h34 HE
|
FFF Enterprises.com
TEMECULA, Calif., Sept. 24, 2024 (GLOBE NEWSWIRE) -- Nufactor®, a specialty infusion company and subsidiary of FFF Enterprises, Inc. announces its 2024 Eric Dostie Memorial College Scholarship...
2024 Research Report | Hematology Analyzers and Reagents Market Anticipated to Reach USD 8.8 Billion by 2029
05 sept. 2024 11h22 HE
|
Research and Markets
Dublin, Sept. 05, 2024 (GLOBE NEWSWIRE) -- The "Hematology Analyzers and Reagents Market Size, Share & Trends by Product (Instrument (PoC, Semi-automated), Reagent, Consumable, Service), Price...
Global Plasma Derived Therapies Market to Surpass US$58 Billion by 2028 with Robust Growth in Immunoglobulin and Albumin Segments
11 juin 2024 09h14 HE
|
Research and Markets
Dublin, June 11, 2024 (GLOBE NEWSWIRE) -- The "Plasma Derived Therapies Market (Immunoglobulin, Hemophilia, Specialty, and Albumin): Insights & Forecast (2024-2028)" report has been added to ...
Spherix Global Insights Expands Therapeutic Area Coverage into Hematology
10 juin 2024 04h00 HE
|
Spherix Global Insights
EXTON, PA, June 10, 2024 (GLOBE NEWSWIRE) -- Spherix Global Insights, a leading independent market intelligence and advisory firm that delivers commercial value to the global life sciences industry,...
Aanastra Inc to Showcase its Peptide-RNA Therapeutics Technology in Multiple Presentations at the American Society for Gene and Cell Therapies (ASGCT) Annual Meeting 2024
02 mai 2024 06h30 HE
|
Aanastra Inc
Aanastra showcases its peptide-RNA therapeutics targeting p53, KRAS and BRCA-1 driven cancers, hemophilia A and PCSK9 for hypercholestrolemia at ASGCT
Comprehensive Analysis of Hematology Collaboration and Licensing Deals (2016-2024) Unveiled
02 mai 2024 05h25 HE
|
Research and Markets
Dublin, May 02, 2024 (GLOBE NEWSWIRE) -- The "Hematology Collaboration and Licensing Deals 2016-2024" report has been added to ResearchAndMarkets.com's offering.A thorough report on hematology...
Global Cell and Gene Therapies in Hemophilia A & B Analysis Report 2024: Market to Reach $2.2 Billion by 2029 - Major Players Are Expected To Intensify Competition
26 avr. 2024 07h22 HE
|
Research and Markets
Dublin, April 26, 2024 (GLOBE NEWSWIRE) -- The "Cell and Gene Therapies in Hemophilia A & B" report has been added to ResearchAndMarkets.com's offering. The global hemophilia A and B CGT...
Hemophilia Treatment Market Poised for Growth, Forecasts Indicate Strong Expansion by 2030
12 mars 2024 13h25 HE
|
Research and Markets
Dublin, March 12, 2024 (GLOBE NEWSWIRE) -- The "Hemophilia Treatment Market Report: Trends, Forecast and Competitive Analysis to 2030" report has been added to ResearchAndMarkets.com's offering. ...